Net Cash Provided by (Used in) Operating Activities |
-1.44M |
USD |
+46.2% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
7.5M |
USD |
+383% |
Dec 31, 2023 |
Q4 2023 |
Net Cash Provided by (Used in) Investing Activities |
111K |
USD |
+1486% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
28M |
shares |
-92% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
14.6M |
shares |
-91.6% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.44M |
USD |
+21.7% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
5K |
USD |
-37.5% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
111M |
USD |
-2.4% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
112M |
USD |
-4.62% |
Dec 31, 2023 |
Q4 2023 |
Property, Plant and Equipment, Gross |
8.13M |
USD |
-77% |
Mar 31, 2024 |
Q1 2024 |
Operating Lease, Liability, Current |
89K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
105M |
USD |
-4.06% |
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
549K |
USD |
+78.2% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Share-based Payment Arrangement, Expense |
289K |
USD |
-63.1% |
Mar 31, 2024 |
Q1 2024 |